Market Overview:
The global direct-to-consumer (DTC) testing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for personalized medicine, rising awareness about DTC tests, and growing number of online test providers. In addition, the increasing incidence of chronic diseases is also contributing to the growth of this market. Based on type, the global DTC testing market can be segmented into routine clinical laboratory testing and medical genetic laboratory testing. The routine clinical laboratory testing segment is expected to account for a larger share of this market than medical genetic laboratory testing during the forecast period. This can be attributed to factors such as lower cost and wider availability of routine clinical laboratory tests as compared with medical genetic laboratory tests. Based on application, the global DTC Testing Market can be divided into doctor office, internet, and others segments. The doctor office segment is anticipated to hold a larger share in terms revenue contribution during 2018–2030 owing higher adoption rates across developed countries coupled with rising patient awareness about benefits associated with early diagnosis through use these services .
Testing Industry Outlook.svg)
Product Definition:
Direct-to-consumer (DTC) testing is a laboratory service that allows patients to test their own blood or other body fluids for the presence of genetic mutations associated with cancer. The importance of DTC testing lies in its ability to allow patients to detect cancer early, when treatment is most likely to be successful.
Routine Clinical Laboratory Testing:
Routine clinical laboratory testing is a group of tests that are performed on a routine basis to monitor the function of the body's major organs and to check for diseases or medical conditions. These tests include blood count, electrolyte imbalance, liver panel test (ALT), kidney panel test ( creatinine), complete blood cell count, erythrocyte sedimentation rate, and C-Reactive Protein.
Medical Genetic Laboratory Testing:
Medical Genetic Laboratory Testing is used for the evaluation of genetic conditions such as Cystic Fibrosis, Hemoglobinopathies, and others. These tests are also known as MGL (Molecular GeneticLaboratory) tests or PCR (Polymerase Chain Reaction) testing.
The global Direct-to-Consumer (DTC) testing market was valued at USD 2.1 billion in 2015.
Application Insights:
The others application segment includes home office, retail clinics and walk-in clinics. The internet is the fastest growing among all DTC testing applications as a result of its ability to reach remote locations in less than 30 minutes. Moreover, consumers prefer online medical tests as they are convenient and easy to access from any location.
Routine clinical laboratory testing dominated the market for DTC testing owing to factors such as increasing prevalence of chronic diseases and rising demand for rapid diagnosis through these tests at affordable prices. Routine clinical laboratory tests include blood glucose test, cholesterol test, vitamin B12 level check & thyroid function test etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of new technologies, and rising consumer awareness about early diagnosis. The U.S., which is at the forefront of this region, has a well-developed healthcare system and an effective regulatory framework that supports it. Moreover, according to a study published by National Cancer Institute (NCI), in 2016 around 1 million people were diagnosed with cancer each year; 50% more than 2015 estimates; and 10% increase per year from 2000 estimates (1).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure coupled with increasing disposable income levels among consumers in emerging countries such as China & India & Indonesia & Thailand etc.; thereby creating lucrative opportunities for industry players over next eight years or so (2).
Growth Factors:
- Increased demand for personalized and convenient healthcare services
- Rising awareness of the benefits of DTC Testing
- Proliferation of digital health technologies
- Growing demand from aging population
- Increasing prevalence of chronic diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Direct-to-Consumer (DTC)Testing Market Research Report
By Type
Routine Clinical Laboratory Testing, Medical Genetic Laboratory Testing
By Application
Doctor Office, Internet, Others
By Companies
23andMe, deCODEme, DNA DTC, GeneByGene, Genecodebook Oy, Genetrainer, MD Revolution, Myriad Genetics, Navigenics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Direct-to-Consumer (DTC)Testing Market Report Segments:
The global Direct-to-Consumer (DTC)Testing market is segmented on the basis of:
Types
Routine Clinical Laboratory Testing, Medical Genetic Laboratory Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Doctor Office, Internet, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- deCODEme
- DNA DTC
- GeneByGene
- Genecodebook Oy
- Genetrainer
- MD Revolution
- Myriad Genetics
- Navigenics
Testing Market Overview.svg)
Highlights of The Direct-to-Consumer (DTC)Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Routine Clinical Laboratory Testing
- Medical Genetic Laboratory Testing
- By Application:
- Doctor Office
- Internet
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Direct-to-Consumer (DTC)Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Direct-to-consumer (DTC) testing is a process of using consumer products to test the safety and effectiveness of new or modified products. DTC testing can be used to evaluate new drugs, medical devices, or other types of products.
Some of the key players operating in the direct-to-consumer (dtc)testing market are 23andMe, deCODEme, DNA DTC, GeneByGene, Genecodebook Oy, Genetrainer, MD Revolution, Myriad Genetics, Navigenics.
The direct-to-consumer (dtc)testing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Direct-to-Consumer (DTC)Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Direct-to-Consumer (DTC)Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Direct-to-Consumer (DTC)Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Direct-to-Consumer (DTC)Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Direct-to-Consumer (DTC)Testing Market Size & Forecast, 2018-2028
4.5.1 Direct-to-Consumer (DTC)Testing Market Size and Y-o-Y Growth
4.5.2 Direct-to-Consumer (DTC)Testing Market Absolute $ Opportunity
Chapter 5 Global Direct-to-Consumer (DTC)Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Direct-to-Consumer (DTC)Testing Market Size Forecast by Type
5.2.1 Routine Clinical Laboratory Testing
5.2.2 Medical Genetic Laboratory Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Direct-to-Consumer (DTC)Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Direct-to-Consumer (DTC)Testing Market Size Forecast by Applications
6.2.1 Doctor Office
6.2.2 Internet
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Direct-to-Consumer (DTC)Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Direct-to-Consumer (DTC)Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Direct-to-Consumer (DTC)Testing Analysis and Forecast
9.1 Introduction
9.2 North America Direct-to-Consumer (DTC)Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Direct-to-Consumer (DTC)Testing Market Size Forecast by Type
9.6.1 Routine Clinical Laboratory Testing
9.6.2 Medical Genetic Laboratory Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Direct-to-Consumer (DTC)Testing Market Size Forecast by Applications
9.10.1 Doctor Office
9.10.2 Internet
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Direct-to-Consumer (DTC)Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Direct-to-Consumer (DTC)Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Direct-to-Consumer (DTC)Testing Market Size Forecast by Type
10.6.1 Routine Clinical Laboratory Testing
10.6.2 Medical Genetic Laboratory Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Direct-to-Consumer (DTC)Testing Market Size Forecast by Applications
10.10.1 Doctor Office
10.10.2 Internet
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Direct-to-Consumer (DTC)Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Direct-to-Consumer (DTC)Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Direct-to-Consumer (DTC)Testing Market Size Forecast by Type
11.6.1 Routine Clinical Laboratory Testing
11.6.2 Medical Genetic Laboratory Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Direct-to-Consumer (DTC)Testing Market Size Forecast by Applications
11.10.1 Doctor Office
11.10.2 Internet
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Direct-to-Consumer (DTC)Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Direct-to-Consumer (DTC)Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Direct-to-Consumer (DTC)Testing Market Size Forecast by Type
12.6.1 Routine Clinical Laboratory Testing
12.6.2 Medical Genetic Laboratory Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Direct-to-Consumer (DTC)Testing Market Size Forecast by Applications
12.10.1 Doctor Office
12.10.2 Internet
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Direct-to-Consumer (DTC)Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Direct-to-Consumer (DTC)Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Direct-to-Consumer (DTC)Testing Market Size Forecast by Type
13.6.1 Routine Clinical Laboratory Testing
13.6.2 Medical Genetic Laboratory Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Direct-to-Consumer (DTC)Testing Market Size Forecast by Applications
13.10.1 Doctor Office
13.10.2 Internet
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Direct-to-Consumer (DTC)Testing Market: Competitive Dashboard
14.2 Global Direct-to-Consumer (DTC)Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 23andMe
14.3.2 deCODEme
14.3.3 DNA DTC
14.3.4 GeneByGene
14.3.5 Genecodebook Oy
14.3.6 Genetrainer
14.3.7 MD Revolution
14.3.8 Myriad Genetics
14.3.9 Navigenics
